Crisdesalazine
Modify Date: 2024-08-03 20:04:23
Crisdesalazine structure
|
Common Name | Crisdesalazine | ||
|---|---|---|---|---|
| CAS Number | 927685-43-6 | Molecular Weight | 325.28200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H14F3NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CrisdesalazineCrisdesalazine (AAD-2004, AAD2004) is a derivative of aspirin that inhibits microsomal PGE(2) synthase-1 (mPGES-1) activity in response to both LPS-treated BV2 cell with IC50 of 230 nM and recombinant human mPGES-1 protein with IC50 of 249 nM in vitro. |
| Name | 2-hydroxy-5-[2-[4-(trifluoromethyl)phenyl]ethylamino]benzoic acid |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C16H14F3NO3 |
|---|---|
| Molecular Weight | 325.28200 |
| Exact Mass | 325.09300 |
| PSA | 69.56000 |
| LogP | 3.83680 |
| Storage condition | 2-8°C |
| unii-11vwk61j69 |
| aad-2004 |
| Crisdesalazine |